Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Teriflunomide can cause hair thinning.

High-dose iron therapy improves anemia without affecting IBD treatment.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Finasteride can cause a unique skin reaction on the penile shaft.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

Most children treated with diphencyprone regrew some or all of their hair.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The iron supplement effectively improves iron levels and reduces symptoms with good tolerance.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.